Cargando…
Global control of COVID-19: good vaccines may not suffice
The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that n...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663111/ https://www.ncbi.nlm.nih.gov/pubmed/34908811 http://dx.doi.org/10.26633/RPSP.2021.148 |
_version_ | 1784613566362419200 |
---|---|
author | Eslava-Schmalbach, Javier Rosero, Eric B. Garzón-Orjuela, Nathaly |
author_facet | Eslava-Schmalbach, Javier Rosero, Eric B. Garzón-Orjuela, Nathaly |
author_sort | Eslava-Schmalbach, Javier |
collection | PubMed |
description | The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that need to be vaccinated to obtain herd immunity is determined through the herd immunity threshold. However, the number of susceptible individuals and the opportunities for contact between infectious and susceptible individuals influence the progress of an epidemic. Thus, in addition to vaccination, control of a pandemic may be difficult or impossible to achieve without other public health measures, including wearing face masks and social distancing. This article discusses the factors that may contribute to herd immunity and control of COVID-19 through the availability of effective vaccines and describes how vaccine effectiveness in the community may be lower than that expected. It also discusses how pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law. |
format | Online Article Text |
id | pubmed-8663111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-86631112021-12-13 Global control of COVID-19: good vaccines may not suffice Eslava-Schmalbach, Javier Rosero, Eric B. Garzón-Orjuela, Nathaly Rev Panam Salud Publica Opinion and Analysis The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that need to be vaccinated to obtain herd immunity is determined through the herd immunity threshold. However, the number of susceptible individuals and the opportunities for contact between infectious and susceptible individuals influence the progress of an epidemic. Thus, in addition to vaccination, control of a pandemic may be difficult or impossible to achieve without other public health measures, including wearing face masks and social distancing. This article discusses the factors that may contribute to herd immunity and control of COVID-19 through the availability of effective vaccines and describes how vaccine effectiveness in the community may be lower than that expected. It also discusses how pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law. Organización Panamericana de la Salud 2021-12-10 /pmc/articles/PMC8663111/ /pubmed/34908811 http://dx.doi.org/10.26633/RPSP.2021.148 Text en https://creativecommons.org/licenses/by/2.5/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license. |
spellingShingle | Opinion and Analysis Eslava-Schmalbach, Javier Rosero, Eric B. Garzón-Orjuela, Nathaly Global control of COVID-19: good vaccines may not suffice |
title | Global control of COVID-19: good vaccines may not suffice |
title_full | Global control of COVID-19: good vaccines may not suffice |
title_fullStr | Global control of COVID-19: good vaccines may not suffice |
title_full_unstemmed | Global control of COVID-19: good vaccines may not suffice |
title_short | Global control of COVID-19: good vaccines may not suffice |
title_sort | global control of covid-19: good vaccines may not suffice |
topic | Opinion and Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663111/ https://www.ncbi.nlm.nih.gov/pubmed/34908811 http://dx.doi.org/10.26633/RPSP.2021.148 |
work_keys_str_mv | AT eslavaschmalbachjavier globalcontrolofcovid19goodvaccinesmaynotsuffice AT roseroericb globalcontrolofcovid19goodvaccinesmaynotsuffice AT garzonorjuelanathaly globalcontrolofcovid19goodvaccinesmaynotsuffice |